NCT01660828

Brief Summary

Strenuous exercise in apparent healthy individuals increases plasma (high sensitive) troponin levels. The underlying mechanism is not yet elucidated, but could be explained by changes due to a mismatch in oxygen demand and supply that mimic those of ischemia and reperfusion injury. If the mechanism underlying the troponin release during exercise is similar to that of ischemia reperfusion injury (IRI), than it should be susceptible to remote ischemic preconditioning (RIPC) as RIPC is a well validated technique to reduce IRI. To test this hypothesis healthy volunteers underwent a strenuous exercise test with or without preceding RIPC.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
20

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Sep 2011

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

September 1, 2011

Completed
3 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2011

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

January 1, 2012

Completed
7 months until next milestone

First Submitted

Initial submission to the registry

July 23, 2012

Completed
17 days until next milestone

First Posted

Study publicly available on registry

August 9, 2012

Completed
Last Updated

August 9, 2012

Status Verified

August 1, 2011

Enrollment Period

3 months

First QC Date

July 23, 2012

Last Update Submit

August 8, 2012

Conditions

Keywords

Exercise induced (high sensitive) troponin releaseIschemia reperfusion injuryRemote ischemic preconditioning

Outcome Measures

Primary Outcomes (1)

  • serum level of high sensitive troponin at several timepoints

    serum level of high sensitive troponin in response to intensive exercise test with or without RIPC at several timepoints

    timepoints t= baseline, 0, 1, 2, 3,4 and 8 hours after finishing exercise

Study Arms (2)

Intensive cycling test preceded by RIPC

ACTIVE COMPARATOR

Intensive cycling test preceded by a RIPC protocol.

Other: remote ischemic preconditioning (RIPC)

No intervention/ RIPC

NO INTERVENTION

Intensive cycling test not preceded by a RIPC protocol.

Interventions

RIPC protocol which consist of three 5-min cycles of bilateral forearm ischemia

Intensive cycling test preceded by RIPC

Eligibility Criteria

Age18 Years - 45 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • age: 18-45 year
  • willing to sign informed consent
  • healthy

You may not qualify if:

  • hypertension (systolic blood pressure \>140 mmHg or diastolic blood pressure \> 90 mmHg)
  • any cardiovascular abnormality in past medical history, physical examination or ECG, including QTc interval
  • drug abuse
  • alcohol abuse (\> 3 units/day)
  • smoking during the last 2 years
  • BMI \>30 kg/m2
  • inability to perform bicycle test
  • the presence of an absolute or relative contra-indication for exercise (table 2 in protocol)
  • the presence of diabetes (fasting glucose \> 6.9 mmol/L, non-fasting glucose \>11.0 mmol/L; if non-fasting glucose is \> 6.9 mmol/L, blood glucose measurement will be repeated in fasting condition and should then not exceed 6.9 mmol/L)
  • total cholesterol in blood 6.6 mmol/L or higher

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Radboud University Nijmegen Medical Centre

Nijmegen, 6500 HB, Netherlands

Location

MeSH Terms

Conditions

Cardiovascular DiseasesReperfusion Injury

Condition Hierarchy (Ancestors)

Vascular DiseasesPostoperative ComplicationsPathologic ProcessesPathological Conditions, Signs and Symptoms

Study Officials

  • G. Rongen, MD, PhD

    Radboud University Nijmegen Medial Centre

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
CROSSOVER
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

July 23, 2012

First Posted

August 9, 2012

Study Start

September 1, 2011

Primary Completion

December 1, 2011

Study Completion

January 1, 2012

Last Updated

August 9, 2012

Record last verified: 2011-08

Locations